| Literature DB >> 35449904 |
Tshifhiwa Ramabulana1, Musawenkosi Ndlovu2, Rebamang A Mosa2, Molahlehi S Sonopo3, Mamoalosi A Selepe1.
Abstract
In the study, ultraperformance liquid chromatography-quadrupole time-of-flight-mass spectrometry analysis of Leucosidea sericea leaf and stem extracts led to the identification of various classes of compounds. Further chromatographic purifications resulted in the isolation of 22 compounds that consisted of a new triterpenoid named leucosidic acid A (1), an acetophenone derivative 2, a phloroglucinol derivative 3, three chromones 4-6, seven pentacyclic triterpenoids 7-13, a phytosterol glucoside 14, a flavonoid 15, and seven flavonoid glycosides 16-22. Nineteen of these compounds including the previously undescribed triterpenoid 1 are isolated for the first time from L. sericea. The structures of the isolated compounds were assigned based on their high-resolution mass spectrometry and nuclear magnetic resonance data. Some of the isolated triterpenoids were evaluated for inhibitory activity against α-amylase, α-glucosidase, and pancreatic lipase. Of the tested compounds, 1-hydroxy-2-oxopomolic acid (7) and pomolic acid (13) showed higher potency on α-glucosidase than acarbose, which is used as a positive control in this study. The two compounds inhibited α-glucosidase with IC50 values of 192.1 ± 13.81 and 85.5 ± 6.87 μM, respectively.Entities:
Year: 2022 PMID: 35449904 PMCID: PMC9016878 DOI: 10.1021/acsomega.2c00096
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Structure of the new compound 1 isolated from the L. sericea extract.
Figure 2MS spectra of compound 1. (A) Low collision energy spectrum and (B) high collision energy spectrum.
1H NMR [500 MHz, δH, Mult. (J in Hz)] and 13C NMR (125 MHz, δc) Data of the Triterpenoid 1 in CD3OD
| position | 13C | 1H | position | 13C | 1H |
|---|---|---|---|---|---|
| 1 | 85.6, CH | 4.22, d (1.5) | 16 | 27.9, CH2 | 2.18, m; 1.49–1.56, m |
| 2 | 211.8, C | 17 | 48.1, C | ||
| 3 | 82.3, CH | 4.06, d (1.5) | 18 | 128.2, CH | 5.39, brs |
| 4 | 46.2, C | 19 | 215.3, C | ||
| 5 | 51.8, CH | 1.56, brs | 20 | 48.3, CH | 2.52–2.57, m |
| 6 | 18.8, CH2 | 1.65–1.83, m | 21 | 28.7, CH2 | 1.33, m; 1.65–1.72, m |
| 7 | 32.8, CH2 | 1.41–1.54, m | 22 | 39.5, CH2 | 1.49–1.56, m; 1.65–1.72, m |
| 8 | 42.4, C | 23 | 29.1, CH3 | 1.17, s | |
| 9 | 56.1, CH | 2.59, m | 24 | 16.4, CH3 | 0.69, s |
| 10 | 49.4, C | 25 | 15.2, CH3 | 0.80, s | |
| 11 | 131.2, CH | 6.67, dd (10.3, 1.5) | 26 | 16.9, CH3 | 0.74, s |
| 12 | 130.4, CH | 5.91, dd (10.3, 3.2) | 27 | 20.2, CH3 | 1.04, s |
| 13 | 143.6, C | 28 | 179.4, C | ||
| 14 | 42.3, C | 29 | 28.3, CH3 | 2.14, s | |
| 15 | 27.3, CH2 | 1.83–1.77, m | 30 | 16.6, CH3 | 1.08, d (7.0) |
Signal that can be interchanged.
Figure 3Key COSY (bold face) and HMBC (arrows) correlations of compound 1.
Inhibitory Activity (IC) of the Isolated Compounds (μM) on α-Amylase, α-Glucosidase, and Pancreatic Lipasea
| compounds (μM) | α-amylase | α-glucosidase | pancreatic lipase |
|---|---|---|---|
| compound | 241.8 ± 57.76 | 1151 ± 175.25 | |
| compound | 130.2 ± 12.68 | 192.1 ± 13.81 | 981.5 ± 36.57 |
| compounds | 123.0 ± 4.46 | 409.9 ± 26.33 | |
| compound | 141.9 ± 6.15 | 85.5 ± 6.87 | 457.7 ± 72.78 |
| compound | 113.2 ± 3.51 | ||
| acarbose | 54.2 ± 6.49 | 347.5 ± 46.23 | |
| orlistat | 3.123 ± 0.035 |
Data expressed as mean ± SD.